Skip to main content
Show — Main navigation
Hide — Main navigation
Home
About
The Chair
Inquiry Team
Expert Groups
Inquiry Intermediaries
Core Participants
Legal Representatives
Financial Reports
Approach
Terms of reference
List of Issues
Statements of approach
Inquiry Principles
News
News
Newsletter Archive
Reports
The Inquiry Report
Additional Compensation Report
First Interim Report
Second Interim Report
Compensation Framework Study
Evidence
Evidence
Hearings Archive
Compensation
Support
NHS Psychological Support
Confidential Psychological Support
Support Groups
Infected Blood Support Schemes
Treatment and aftercare
Medical Evidence
Expenses Guidance
Contact us
Search
Accessibility Tool
Zoom in
Zoom out
Reset
Contrast
Accessibility tool
Listen
Get in touch
Quick Exit
Subscribe to Search results
Search
Sort your search results
Relevance
Title
Changed
Responding to the requirement to seek Home Affairs Committee clearance before policy approval, Andrew Lansley stated in his written statement that "The Deputy PM will have responded giving HA Committee clearance."
Published on:
01 August, 2024
Recommendations of financial relief in relation to the contaminated blood review were presented to Anne Milton which set out a variety of options for the Government to consider.
Published on:
01 August, 2024
A report was produced entitled "Review of the support available to individuals infected with Hepatitis C and/or HIV by NHS-supplied blood transfusions or blood products and their dependants."
Published on:
01 August, 2024
Anne Milton set out, in a undated letter to David Cameron, a summary of the report by the Department of Health on the financial support available for individuals infected with Hepatitis C/HIV.
Published on:
01 August, 2024
In his written statement, Sir John Major described the Government as a "great tanker and takes time to turn around" in relation to payments to non-haemophilia patients who were infected with HIV through blood transfusions.
Published on:
01 August, 2024
In Roderick Murray's "Viral Hepatitis Bulletin of the New York Academy of Medicine", he showed that an exceptionally small amount of blood containing a virus could be infective.
Published on:
01 August, 2024
In Barker et al's "Transmission of Serum Hepatitis", featured in the Journal of the American Medical Association, the high infectivity of hepatitis was echoed.
Published on:
01 August, 2024
In Dr Rosemary Bigg's book "The Treatment of Haemophilia A and B and von Willebrand's Disease", she cited Roderick Murray's 1955 work, which identified that even an exceptionally small amount of blood containing a virus could be infective.
Published on:
01 August, 2024
A study carried out by Gocke said that, in total, 74% of the recipients of blood con_taining the Australia antigen exhibited either hepatitis or an immune response.
Published on:
01 August, 2024
At a meeting of blood transfusion officers they discussed the proposal that the pool size used at the Cambridge drying plant for plasma should be reduced to a size of no more than 10 donors.
Published on:
01 August, 2024
The British Medical Journal article had a footnote which said that "We understand that only small pools are now used by the Ministry of Health for the preparation of blood products."
Published on:
01 August, 2024
In a letter to a Dr Lehane, Dr Maycock stated that all large pool plasma should be replaced with small pool plasma and that the large pool plasma could be diverted to Liverpool so that the small pools could be examined for infectivity.
Published on:
01 August, 2024
A study of British Army records concluded that plasma was more icterogenic than whole blood and one reason for this was likely because one bottle of plasma came from a pool to which many donors contributed.
Published on:
01 August, 2024
In a letter to Dr Maycock, Dr Drummond stated that he did not think it was justifiable to continue to issue large pool plasma which had a 10% incidence of homologous serum jaundice as opposed to 1% for small pools, and that were a case of this to go to court it would not be justifiable since it was practicable to make small pools.
Published on:
01 August, 2024
A study by Biggs in the British Journal of Haematology described the process of preparing Factor 9 concentrate using 45-50 litres of plasma.
Published on:
01 August, 2024
Pools used to prepare antihemophilic factor were 14-22 litres in size. This amounted to the use of pools made from a maximum of 90-110 donations. There was said to be no "contra-indications to the prolonged or repeated use of the product."
Published on:
01 August, 2024
Dr Peter Wolf commented "The risk of contamination of blood with the virus of infective hepatitis limits a single fractionation batch to a donor pool of 50" but "Human A.H.F. concentrate, produced in this way at multiple centres throughout the country, could provide sufficient to treat all the known classical haemophiliacs in Great Britain."
Published on:
01 August, 2024
Dr Maycock and Leon Vallet proposed to "retain the present pool size (30L) because of the risk of transmitting serum hepatitis."
Published on:
01 August, 2024
A working party on human antihaemophilic globulin decided "it was considered inadvisable, when planning increased production, to increase the plasma pool volume much above this size (30-40 litres in volume), unless further observations indicated that the risk was smaller than the present series of cases suggested."
Published on:
01 August, 2024
Dr Maycock wrote that in the UK antihaemophilic globulin ("AHG") was made from donor pools of 60-100 donors, and described a "paucity of reports of hepatitis" associated with this.
Published on:
01 August, 2024
Pagination
First page
First
Previous page
Previous
…
Page
2098
Page
2099
Page
2100
Page
2101
Current page
2102
Page
2103
Page
2104
Page
2105
Page
2106
…
Next page
Next
Last page
Last